Get alerts when LRCX reports next quarter
Set up alerts — freeLam’s shares fell 11.8% after earnings, despite record September-quarter results, as investors may have focused on the gap between strong demand and the company’s ability to supply it: management said clean-room availability and component constraints could limit deliveries in 2027. The outlook also remains preliminary, with Lam citing WFE spending above $200 billion in 2027 while warning that supply constraints may prevent the industry from fully meeting end demand.
See LRCX alongside your other holdings
Add to your portfolio — freeTrack Lam Research Corporation in your portfolio with real-time analytics, dividend tracking, and more.
View LRCX Analysis